(R)-3-(4-Fluoro-2-nitrophenoxy)pyrrolidine hydrochloride, 95.0%, 1g

Ethyl 5-chloro-4-nitrothiophene-2-carboxylate, 95.0%, 100g

8-Methoxy-2-(trifluoromethyl)-quinolin-4-ol, 95.0%, 5g

4-(4-(Trifluoromethoxy)phenoxy)piperidine, 95.0%, 25g

2-ethyl-1-isopropylpiperazine, 95.0%, 10g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 150, 20000 ml, 315 mm, 1 Piece

4-[(1R,2R)-2-Benzyloxy-1-methyl-propoxy]-2-chloro-5-(trifluoromethyl)pyrimidine, 98%, 500mg

1-Pentadecene>95.0%(GC)5mL

METHYL 2-(4-AMINOPHENOXY)BENZOATE, 95.0%, 250mg

(5-Fluoro-2-(methoxymethoxy)phenyl)boronic acid, 95.0%, 10g

(S)-4-Methyl-1,3-dioxolan-2-one, 95.0%, 5g

(S)-tert-Butyl (pyrrolidin-2-ylmethyl)carbamatehydrochloride, 95.0%, 100mg

3-(3-Methoxyphenyl)-3-oxo-propionic acid methylester, 95.0%, 1g